R
VTRS icon

Rebalance’s Viatris VTRS Stock Holding History

Rebalance’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-244
Closed -$2.72K – 135
2022
Q4 		$2.72K Buy
+244
New +$2.55K ﹤0.01% 130

Other funds holding VTRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Rebalance's VTRS Position: Q1 2023 in Review

Rebalance sold out of Viatris (VTRS) in Q1 2023, closing a stake of 244 shares — an estimated $2.72K sold.

Rebalance first reported a position in VTRS in Q4 2022 and held it in 1 quarter. The position peaked at $2.72K in Q4 2022. 990 funds tracked by Wall St. Rank hold VTRS as of Q1 2023.

  • Rebalance reported no remaining Viatris position as of Q1 2023 after selling out during the quarter.
  • Rebalance sold 244 Viatris shares in Q1 2023, an estimated $2.72K.
  • Rebalance first reported a position in Viatris in Q4 2022 and held it in 1 quarter.
  • Rebalance's Viatris position peaked at $2.72K in Q4 2022.
  • 990 funds tracked by Wall St. Rank held Viatris as of Q1 2023.

Based on Rebalance's 13F filing for Q1 2023, filed 3 May 2023.